Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: a comparative study with HbA1c and glycated albumin

Background 1,5-Anhydroglucitol (1,5-AG) is a new blood glucose control marker reflecting temporary glucose elevations. However, 1,5-AG is of limited value in patients with advanced renal insufficiency. The aim of the present study was to assess the correlation between 1,5-AG levels and renal functio...

Full description

Saved in:
Bibliographic Details
Main Authors: Hasslacher, Christoph (Author) , Kulozik, Felix (Author)
Format: Article (Journal)
Language:English
Published: 2016
In: Journal of diabetes
Year: 2015, Volume: 8, Issue: 5, Pages: 712-719
ISSN:1753-0407
DOI:10.1111/1753-0407.12354
Online Access:Verlag, Volltext: https://doi.org/10.1111/1753-0407.12354
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/1753-0407.12354
Get full text
Author Notes:Christoph Hasslacher and Felix Kulozik

MARC

LEADER 00000caa a2200000 c 4500
001 1670730824
003 DE-627
005 20230426082408.0
007 cr uuu---uuuuu
008 190807r20162015xx |||||o 00| ||eng c
024 7 |a 10.1111/1753-0407.12354  |2 doi 
035 |a (DE-627)1670730824 
035 |a (DE-599)KXP1670730824 
035 |a (OCoLC)1341235454 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hasslacher, Christoph  |e VerfasserIn  |0 (DE-588)106823671  |0 (DE-627)690944403  |0 (DE-576)169099709  |4 aut 
245 1 0 |a Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III  |b a comparative study with HbA1c and glycated albumin  |c Christoph Hasslacher and Felix Kulozik 
264 1 |c 2016 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First published: 28 November 2015 
500 |a Gesehen am 07.08.2019 
520 |a Background 1,5-Anhydroglucitol (1,5-AG) is a new blood glucose control marker reflecting temporary glucose elevations. However, 1,5-AG is of limited value in patients with advanced renal insufficiency. The aim of the present study was to assess the correlation between 1,5-AG levels and renal function in patients with earlier stages of nephropathy compared with another two markers of diabetes control, namely HbA1c and glycated albumin (GA). Methods The following parameters were measured in 377 patients with type 2 diabetes: HbA1c, serum concentrations of 1,5-AG, GA and creatinine, hemoglobin, urinary albumin/creatinine ratio, and urinary excretion of α1-microglobulin (A1M). Estimated glomerular filtration rate (eGFR) was calculated according to the Cockgroft-Gault formula. Results There was a negative correlation between 1,5-AG and renal function (r = −0.18; P < 0.001). Concentrations of 1,5-AG were, on average, 27.2% lower in patients with glomerular hyperfiltration (eGFR >120 mL/min) compared with patients with moderate renal impairment (eGFR 30-59 mL/min; P = 0.016). In contrast, HbA1c, GA levels and urinary A1M excretion did not differ between the two patient groups. The mean age of patients with eGFR 30-59 mL/min was substantially higher than that of patients with glomerular hyperfiltration (P < 0.001). Thus, an age-related change in the renal glucose threshold could be the reason for the observed correlation between 1,5-AG and renal function. Conclusions In clinical practice, age and renal function must be taken into consideration when interpreting 1,5-AG levels, even in the absence of advanced renal impairment. 
534 |c 2015 
650 4 |a 1 
650 4 |a 5-anhydroglucitol 
650 4 |a 5-脱水葡萄糖醇 
650 4 |a diabetes control 
650 4 |a glycated albumin 
650 4 |a HbA1c 
650 4 |a renal function 
650 4 |a 糖化白蛋白 
650 4 |a 糖尿病控制 
650 4 |a 肾功能。 
700 1 |a Kulozik, Felix  |d 1980-  |e VerfasserIn  |0 (DE-588)1013215451  |0 (DE-627)704982897  |0 (DE-576)346259339  |4 aut 
773 0 8 |i Enthalten in  |t Journal of diabetes  |d Oxford [u.a.] : Wiley-Blackwell, 2009  |g 8(2016), 5, Seite 712-719  |h Online-Ressource  |w (DE-627)594772397  |w (DE-600)2485432-3  |w (DE-576)305355953  |x 1753-0407  |7 nnas  |a Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III a comparative study with HbA1c and glycated albumin 
773 1 8 |g volume:8  |g year:2016  |g number:5  |g pages:712-719  |g extent:8  |a Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III a comparative study with HbA1c and glycated albumin 
856 4 0 |u https://doi.org/10.1111/1753-0407.12354  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/1753-0407.12354  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190807 
993 |a Article 
994 |a 2016 
998 |g 1013215451  |a Kulozik, Felix  |m 1013215451:Kulozik, Felix  |d 60000  |e 60000PK1013215451  |k 0/60000/  |p 2  |y j 
998 |g 106823671  |a Hasslacher, Christoph  |m 106823671:Hasslacher, Christoph  |d 50000  |e 50000PH106823671  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1670730824  |e 3504961511 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"recId":"1670730824","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["First published: 28 November 2015","Gesehen am 07.08.2019"],"person":[{"family":"Hasslacher","given":"Christoph","roleDisplay":"VerfasserIn","display":"Hasslacher, Christoph","role":"aut"},{"display":"Kulozik, Felix","roleDisplay":"VerfasserIn","role":"aut","family":"Kulozik","given":"Felix"}],"title":[{"title":"Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III","subtitle":"a comparative study with HbA1c and glycated albumin","title_sort":"Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III"}],"relHost":[{"recId":"594772397","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III a comparative study with HbA1c and glycated albuminJournal of diabetes","note":["Gesehen am 02.08.2022"],"titleAlt":[{"title":"JDB"}],"part":{"year":"2016","issue":"5","pages":"712-719","volume":"8","text":"8(2016), 5, Seite 712-719","extent":"8"},"pubHistory":["1.2009 -"],"title":[{"title":"Journal of diabetes","title_sort":"Journal of diabetes"}],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["publ. in association with Ruijin Hospital, Shanghai JiaoTong University School of Medicine"]},"id":{"issn":["1753-0407"],"zdb":["2485432-3"],"eki":["594772397"],"doi":["10.1111/(ISSN)1753-0407"]},"origin":[{"dateIssuedDisp":"2009-","publisher":"Wiley-Blackwell","dateIssuedKey":"2009","publisherPlace":"Oxford [u.a.]"}]}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Christoph Hasslacher and Felix Kulozik"]},"id":{"doi":["10.1111/1753-0407.12354"],"eki":["1670730824"]},"origin":[{"dateIssuedDisp":"2016","dateIssuedKey":"2016"}]} 
SRT |a HASSLACHEREFFECTOFRE2016